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Andrea Mangiameli, MD,* Yohei Ohno, MD,* Guilherme F. Attizzani, MD,*y Davide Capodanno, MD, PHD,*
Corrado Tamburino, MD, PHD*zA 48-year-old man who underwent uneventful3.0  28 mm bioresorbable vascular scaffold(BVS) implantation on the mid left anterior
descending coronary artery for stable angina, pre-
sented 15 months later with unstable angina. Coro-
nary angiography showed a critical in-scaffold
restenosis with Thrombolysis In Myocardial Infarc-
tion ﬂow grade 2 (Figures 1A and 1B). Optical coher-
ence tomography assessment (Ilumien, St. Jude
Medical, St. Paul, Minnesota) was performed to eluci-
date the mechanism of BVS failure, which revealed
heterogeneous tissue coverage within the scaffold
(Figure 1C, cross sections D to G), as follows: 1) neoin-
timal rupture with mural white thrombus at the
rupture site (Figures 1D and 1E); 2) a low signal-
intensity scaffold coverage pattern with dorsal atten-
uation and marked shadowing of the scaffold struts
(Figures 1E and 1F); and 3) a normal pattern of neoin-
timal hyperplasia (i.e., high signal intensity)
(Figure 1G). The minimal lumen area was 1.3 mm2.
An excellent angiographic result was obtained after
plain old balloon angioplasty and abciximab infusion.
Metallic stents fail to fully protect the vessel from
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late lumen enlargement; in addition, they are sup-
posed to promote plaque stability and passivation
of vulnerable plaques by providing a uniform homo-
geneous neointimal layer (1). However, BVS have
not eliminated the early- and mid-term presence of
polymer and antiproliferative drugs, both previously
associated with a pro-inﬂammatory milieu. The time
course of neoatherosclerosis in the present case (i.e.,
15 months after the index procedure) resembles
that of metallic drug-eluting stents (2). Although it
might be a rare event, neoatherosclerosis could be
considered a potential cause of late failure even with
BVS. Replication of this ﬁnding in BVS populations
is warranted to determine the incidence and the
potential long-term clinical implications of neo-
atherosclerosis in this setting.
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FIGURE 1 Angiograms and OCT Images of Scaffold Failure at 15 Months
(A and B) Angiograms demonstrate focal in-scaffold restenosis. White arrowheads show the position of the platinum markers of the bio-
resorbable vascular scaffold. (C) The dashed lines in the longitudinal optical coherence tomography (OCT) view correspond to the respective
cross sections (D to G). (D) Neointimal rupture (white arrow) with mural thrombus (red asterisk) at the rupture site protruding into the lumen.
(E) Mural thrombus (red asterisk) with highly attenuating area (white asterisk). (F) Low signal-intensity scaffold strut coverage pattern with
dorsal attenuation (white asterisks) and marked shadowing of the scaffold struts (note that only a few struts are depicted). (G) Normal
pattern of neointimal hyperplasia (i.e., high signal intensity) (note that the scaffold struts are clearly visible along the entire vessel
circumference).
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